5th of May, 2022 SAKK's post-AACR

2nd Swiss Post Annual Meeting of the American Association for Cancer Research

 

Join us for the most exciting from this year’s AACR:

live online or on site at the Marriott Hotel in Zurich

Register For FreeWatch Recording Now

Chairs:

Markus Jörger, MD-PhD

Markus Jörger, MD-PhD

Cantonal Hospital St. Gallen

Anastasios Stathis, MD

Anastasios Stathis, MD

Oncology Institute of Southern Switzerland

This post-AACR meeting took place during the SAKK Semi-Annual Meeting and is now available on demand.

Scientific Committee:

Giuseppe Curigliano, MD-PhD

Giuseppe Curigliano, MD-PhD

European Institute of Oncology, Milano

Paola Luciani, PhD

Paola Luciani, PhD

University of Bern

Berna Özdemir, MD-PhD

Berna Özdemir, MD-PhD

Inselspital, University Hospital Bern

Berend Snijder, PhD

Berend Snijder, PhD

ETH Zurich

Registration is still open and free of charge!

The Annual Meeting of the American Association for Cancer Research took place from April 8-13, 2022. The SAKK took this opportunity to organize the second PostAACR event for Switzerland. This event offered the opportunity to inform and exchange information about the current state of cancer research. The program of the AACR Virtual Annual Meeting highlighted novel and significant research results that have enormous promise for cancer patients.

This SAKK event lasted 2.5 hours and is still free of charge for all participants, but requires the registration below. Industry representatives are admitted only within the scope of their sponsorship.

We look forward to your participation!

3 CME Credits SGMO

AGENDA: SAKK’s Post-AACR 2022

Thursday, 5 May 2022 – from Zurich Marriott Hotel

17.45

Welcome & Introduction

17.50 – 18.30

Keynote-Lecture

Drug Development: How can academia and industry work better together?
Giuseppe Curigliano

18.30 – 19.15

Cancer Biology / Cancer Environment, chaired by Markus  Joerger

New anticancer drugs on the horizon
Paola Luciani

Big data and computational approaches
Berend Snijder

19.15 – 20.15

Trends in Early Clinical Research, chaired by Anastasios Stathis

New developments on melanoma and prostate cancer
Berna Özdemir

What’s new in targeted anticancer therapy
Anastasios Stathis

What’s new in immunotherapy
Markus Jörger

20.15

Closure

from 20.20

End & Networking Apéro

SAKK Partners

This meeting is kindly supported by SAKK’s partners with no influence on the content

Main Sponsor

Pfizer

Silver

Bronze

BMS Logo

FAQs

Will I be able to re-access the videos?
Yes, absolutely. The content is recorded and made available within 24 hours on our portal so that you can play it on demand as often as you like.

Why do you need my details for registration?
In accordance with Swiss and European regulations, we require some information about you for verification purposes to ensure that the content of our initiatives is aimed at healthcare professionals and those involved in the science, management and treatment of cancer. We will not share your personal details with any sponsor or any third party – promised!

How can I get involved in the discussion?
During the live webinar, you may submit your questions to our panel of experts and with that interact and influence the discussion.

Registration is still open!